Locally Advanced Pancreatic Cancer Recruiting Phase 3 Trials for Gemcitabine (DB00441)

Also known as: Pancreatic Carcinoma Stage II / Locally advanced Pancreatic cancer

DBCOND0040768 (Locally Advanced Pancreatic Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03126435EndoTAG-1 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX TreatmentTreatment
NCT03257033Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCTreatment
NCT02043288Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic CancerTreatment